% | $
Quotes you view appear here for quick access.

Navidea Biopharmaceuticals, Inc Message Board

  • eterso3 eterso3 May 3, 2013 1:07 PM Flag

    Navb meeting with jeffries

    Jeffries sell side merger and acquisition their main product including big pharm from their web site

    Completed over 250 M&A transactions with deal value of over $145 billion since the beginning of 2011
    M&A is the largest product area at Jefferies, representing approximately 50% of investment banking revenue1
    Highest percentage of sole-advised M&A transactions of any major investment bank2
    One of Wall Street's leading sell-side advisors: Approximately 70% of our M&A transactions are sell-side transactions
    Approximately 75% of sale assignments completed with strategic acquirers
    Over 35% of sale assignments completed with cross-border counterparties
    Since 2011, mean EV/EBITDA multiple of 13.5x achieved for Jefferies' public company sell-side clients versus 9.6x for the overall public sell-side market

    2011 M&A Deal of the Year awarded by The Deal magazine: Jefferies acted as sole financial advisor to Samson Investment Company in the $7.2 billion sale to an investor group led by KKR
    2011 Deal of the Year by the New York Times’ DealBook: Jefferies acted as sole financial advisor to iGATE Corporation in the $1.5 billion acquisition of Patni Computer Systems

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • the meeting wont help NAVB share price doesn't matter.

    • Meeting with Jefferies and Co. is always a welcome news even the company is not for sale. Every company should have that open option for merger, acquition and be valued from time to time. Merging with another company with income and consolodate expense should always be on the table.


      Sentiment: Strong Buy

      • 1 Reply to who_dat75
      • Jefferies Global Healthcare Conference June 3-6-gathering of institutional/private equity investors, VCs and leading executives

        Jefferies 2013 Global Healthcare Conference
        June 3 - 6, 2013
        New York City

        We are pleased to announce the Jefferies 2013 Global Healthcare Conference taking place June 3-6 in New York City.

        Following the success of last year’s conference, with over 300 presenting companies and 2,000 attendees, the 2013 conference will again feature an extensive range of public & private healthcare companies across the biopharmaceuticals, life sciences, healthcare services, healthcare IT and medical technology sectors.

        The four day event will be comprised of concurrent tracks of company presentations as well as Q&A breakout sessions, investor meetings, business-to-business meetings and thematic panel discussions. This global gathering of institutional investors, private equity investors, VCs and leading executives will address near- and long-term investment opportunities and discuss the mechanisms driving healthcare in the U.S. and internationally.

        You must have a Jefferies representative in order to register."

0.8358-0.0075(-0.89%)10:24 AMEST